Previous 10 | Next 10 |
Expanded indication provides access to robotic technology in vascular procedures from head to toe Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that it received approval from the Australian Therapeutic Goods ...
Brazil’s Albert Einstein Jewish Hospital continues reputation as pioneer in medical robotics Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, announce...
This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc...
Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, today announced that the Company will join the broad-market Russell 3000 ® Index at the conclusion of the 2019 Russell ...
This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc...
The stock price of Corindus Vascular Robotics, Inc. ( CVRS ) has been steadily climbing up during the past year. It has gone up by 87% for the past year, reaching $3.00 as of June 2019. This is a rare success considering the US equity market has been declining since the latter half of 2018, du...
SIMPLIFYING RECENT INNOVATON ANNOUNCEMENTS AT HRS IN TERMS OF REVENUE AND PROFITABLITY; STRONG POTENTIAL OUTLOOK WITH OVER $60 MILLION IN SALES AND LARGE PROFITS FROM JUST EXISTING CUSTOMER BASE Stereotaxis is a global pioneer and leader of robotics for endovascular surgery with a fantasti...
Case broadcast live to thousands of EuroPCR attendees from Clinique Pasteur in France Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today its CorPat...
Company will highlight CorPath GRX capabilities in complex vascular procedures Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that it will show...
Company to feature latest milestones and technology advancements in vascular robotics at SCAI 2019 Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, will sponsor ...
News, Short Squeeze, Breakout and More Instantly...
Corindus Vascular Robotics Inc. (DE) Company Name:
CVRS Stock Symbol:
NYSE Market:
Texas A&M’s Robin Murphy has deployed robots at 29 disasters, including three building collapses, two mine disasters and an earthquake as director of the Center for Robot-Assisted Search and Rescue. She has also served as a technical search specialist with the Hillsboro County (Flor...
At a special meeting today, stockholders of Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS) approved the adoption of the Agreement and Plan of Merger (the “Merger Agreement”), dated as of August 7, 2019, by and amo...
Breakfast symposium and conference activities to highlight capabilities of vascular robotic technology and advancements in automation and remote treatment Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading devel...